Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
869.2500 0.05 (0.01%)
NSE Jun 24, 2025 15:31 PM
Volume: 347.4K
 

logo
Natco Pharma Ltd.
06 Nov 2017
869.25
0.01%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 7% YoY to | 427 crore (I-direct estimate: | 496 crore). The revenues were lower than I-direct estimates mainly due to increase in competition in Hep C sales EBITDA margins improved 580 bps YoY to 28.6% (I-direct estimate: 31%) mainly due to a favourable product mix. EBITDA grew 16% to | 122 crore (I-direct estimate: | 154 crore) Adjusted net profit increased 28% YoY to | 85 crore (I-direct...
Natco Pharma Ltd. has lost -36.62% in the last 6 Months
More from Natco Pharma Ltd.
All earning calls
Investor presentations from Natco Pharma Ltd.
All investor presentations